Asia Pacific BioSurgery Market was worth USD 3.89 billion in 2019 and estimated to be growing at a CAGR of 10.43%, to reach USD 6.39 billion by 2024 during the forecast period 2019-2024.
Biomaterials are biologically compatible glues used to seal surgical incisions, or lubricants to help joint movement or support structures on which living tissue is grown or shaped, but the term also covers biocompatible materials such as hip replacements and artificial pacemakers. It also includes bio-therapeutic techniques such as gene and cellular therapies. All these techniques combined together make up the field of bio-surgery.
Biosurgery products help enhance the work efficiency of physicians by controlling surgery-related difficulties inexpensive and complicated surgeries. It utilizes biomaterial, therapeutic, and sophisticated device technologies to improve the health of patients in the orthopaedic and post-surgery care departments.
The major factor affecting the Bio Surgery market is the increasing number of various surgeries carried out due to changing lifestyles. Additionally, the popularity of sports has led to an increase in the number of spine related injuries. This along with the rise in geriatric population are the major drivers of the market in the region. However, the industry is still plagued by the increasing costs of surgeries, the increasing demand for minimally invasive techniques and the stringent government regulations and reimbursement policies, all of which restrain the market growth.
This research report on the Asia Pacific BioSurgery Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
By Type : Sealants, Haemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Substitutes and Staple line Reinforcement Agents
By Application: Orthopaedic, General, Neurological, Cardiovascular, Reconstructive, Gynaecological, Urological and thoracic Surgeries.
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC
Major Companies in the Market:
Some of the Major Companies leading the Asia Pacific BioSurgery Market Profiled in the Report are Baxter International, C.R. Bard, Johnson & Johnson, Covidien plc., Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Type
5.1.1 Introduction
5.1.2 Sealants
5.1.2.1 Natural
5.1.2.2 Synthetic and Semi-Synthetic
5.1.3 Haemostatic Agents
5.1.4 Adhesion Barriers
5.1.4.1 Synthetic
5.1.4.2 Natural
5.1.5 Soft Tissue Attachments
5.1.5.1 Synthetic Meshes
5.1.5.2 Biological Meshes
5.1.7 Bone Graft Substitutes
5.1.7.1 Bone Allografts
5.1.7.2 Demineralized Bone Matrix
5.1.7.3 Bone Morphogenetic Proteins
5.1.7.4 Synthetic Bone Grafts
5.1.8 Staple Line Reinforcement Agents
5.1.9 Y-o-Y Growth Analysis, By Type
5.1.10 Market Attractiveness Analysis, By Type
5.1.11 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Orthopaedic
5.2.3 General
5.2.4 Neurological
5.2.5 Cardiovascular
5.2.6 Reconstructive
5.2.7 Gynaecological
5.2.8 Urological
5.2.9 Thoracic
5.2.10 Y-o-Y Growth Analysis, By Application
5.2.11 Market Attractiveness Analysis, By Application
5.2.12 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Baxter International
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C.R. Bard
8.3 Covidien PLC
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 B.Braun Melsungen AG
8.8 Cryolife Inc.
8.9 Stryker Corporation
8.10 Haemostasis LLC
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
